205 related articles for article (PubMed ID: 34894725)
1. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.
Ren J; Lu X; Hall G; Privratsky JR; Robson MJ; Blakely RD; Crowley SD
Am J Physiol Renal Physiol; 2022 Feb; 322(2):F164-F174. PubMed ID: 34894725
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria.
Brähler S; Ising C; Hagmann H; Rasmus M; Hoehne M; Kurschat C; Kisner T; Goebel H; Shankland S; Addicks K; Thaiss F; Schermer B; Pasparakis M; Benzing T; Brinkkoetter PT
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1473-85. PubMed ID: 22975019
[TBL] [Abstract][Full Text] [Related]
3. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy.
Yi M; Zhang L; Liu Y; Livingston MJ; Chen JK; Nahman NS; Liu F; Dong Z
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F74-F84. PubMed ID: 28404589
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
[TBL] [Abstract][Full Text] [Related]
5. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
Logar CM; Brinkkoetter PT; Krofft RD; Pippin JW; Shankland SJ
Kidney Int; 2007 Aug; 72(4):489-98. PubMed ID: 17554257
[TBL] [Abstract][Full Text] [Related]
6. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of podocyte FAK protects against proteinuria and foot process effacement.
Ma H; Togawa A; Soda K; Zhang J; Lee S; Ma M; Yu Z; Ardito T; Czyzyk J; Diggs L; Joly D; Hatakeyama S; Kawahara E; Holzman L; Guan JL; Ishibe S
J Am Soc Nephrol; 2010 Jul; 21(7):1145-56. PubMed ID: 20522532
[TBL] [Abstract][Full Text] [Related]
8. Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis.
Dai Y; Gu L; Yuan W; Yu Q; Ni Z; Ross MJ; Kaufman L; Xiong H; Salant DJ; He JC; Chuang PY
Kidney Int; 2013 Nov; 84(5):950-61. PubMed ID: 23842188
[TBL] [Abstract][Full Text] [Related]
9. Signal regulatory protein α protects podocytes through promoting autophagic activity.
Li L; Liu Y; Li S; Yang R; Zeng C; Rong W; Liang H; Zhang M; Zhu X; Kidder K; Liu Y; Liu Z; Zen K
JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30888336
[TBL] [Abstract][Full Text] [Related]
10. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.
Ma J; Matsusaka T; Yang HC; Zhong J; Takagi N; Fogo AB; Kon V; Ichikawa I
Pediatr Res; 2011 Jul; 70(1):83-9. PubMed ID: 21451433
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury.
Arif E; Solanki AK; Srivastava P; Rahman B; Fitzgibbon WR; Deng P; Budisavljevic MN; Baicu CF; Zile MR; Megyesi J; Janech MG; Kwon SH; Collier J; Schnellmann RG; Nihalani D
Kidney Int; 2019 Sep; 96(3):656-673. PubMed ID: 31262488
[TBL] [Abstract][Full Text] [Related]
12. Role of C/EBP-α in Adriamycin-induced podocyte injury.
Zhong F; Wang W; Lee K; He JC; Chen N
Sci Rep; 2016 Sep; 6():33520. PubMed ID: 27644413
[TBL] [Abstract][Full Text] [Related]
13. Podocyte loss involves MDM2-driven mitotic catastrophe.
Mulay SR; Thomasova D; Ryu M; Kulkarni OP; Migliorini A; Bruns H; Gröbmayr R; Lazzeri E; Lasagni L; Liapis H; Romagnani P; Anders HJ
J Pathol; 2013 Jul; 230(3):322-35. PubMed ID: 23749457
[TBL] [Abstract][Full Text] [Related]
14. Injured Podocytes Are Sensitized to Angiotensin II-Induced Calcium Signaling.
Binz-Lotter J; Jüngst C; Rinschen MM; Koehler S; Zentis P; Schauss A; Schermer B; Benzing T; Hackl MJ
J Am Soc Nephrol; 2020 Mar; 31(3):532-542. PubMed ID: 31924670
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
[TBL] [Abstract][Full Text] [Related]
16. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
Wang H; Misaki T; Taupin V; Eguchi A; Ghosh P; Farquhar MG
J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α.
Dai Y; Chen A; Liu R; Gu L; Sharma S; Cai W; Salem F; Salant DJ; Pippin JW; Shankland SJ; Moeller MJ; Ghyselinck NB; Ding X; Chuang PY; Lee K; He JC
Kidney Int; 2017 Dec; 92(6):1444-1457. PubMed ID: 28756872
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
19. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
